Hayashibara

We are glad to present our new webinar in collaboration with our partner Nagase Viita: Smarter Stabilization for Lipid Nanoparticles:...

Abstract Vaccines rely on a global cold chain to maintain vaccine potency throughout the product life cycle. Existing vaccine thermostabilization...

Moving Glycoscience Forward How does the Sucrose SG product’s manufacturing process fit into your company’s strong sustainability commitments? Our proprietary...

Abstract Cilnidipine is used to treat hypertension. However, it has poor solubility and undergoes extensive first-pass metabolism, which leads to...

Abstract Background: Dry powders offer the potential to increase stability and reduce cold-chain requirements associated with the distribution of vaccines and...

Abstract Previously, a nasal powder formulation of the influenza vaccine was proposed to ensure its stability over fifteen months at...

Abstract Solid-state protein formulations are known to exhibit enhanced storage stability compared to their liquid dosage form counterparts. pH is...

PRESS RELEASE Nagase Viita Co., Ltd. (Headquarters: Shimoishii, Kita-ku, Okayama; Representative Director: Naoki Yasuba), a member of the NAGASE Group,...

Abstract Pharmaceutical peptides are susceptible to aggregation in solution, making stabilization by addition of suitable excipients essential. To investigate this...

Abstract Ensuring children adhere to their prescribed medication can be challenging, particularly when a large number of medicines on the...